18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients

European Journal of Endocrinology

Volumn 150, Issue 6, 2004, Pages 789-792

  Tenenbaum, Florence ^a   Groussin, Lionel ^a   Foehrenbach, Hervé ^b   Tissier, Frédérique ^a   Gouya, Hervé ^a   Bertherat, Jérôme ^a   Dousset, Bertrand ^a   Legmann, Paul ^a   Richard, Bruno ^a   Bertagna, Xavier ^a  

^a Hôpital Cochin ^*  (France)

^b Serv de Med Nucleaire   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL; FLUCIS; FLUORODEOXYGLUCOSE F 18; NORCHOL; PENTETATE TECHNETIUM TC 99M; DIAGNOSTIC AGENT;

ADRENAL CANCER; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ADRENAL METASTASIS; ADRENAL SCINTISCANNING; ADRENALECTOMY; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HORMONE DETERMINATION; HUMAN; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; KIDNEY CANCER; LIVER METASTASIS; MALE; OUTCOMES RESEARCH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR VOLUME; ADRENAL CORTEX; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HISTORY; LIVER; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; SECRETION;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; HISTORY, 18TH CENTURY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3242660154     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1500789     Document Type: Article

References (15)

1. Gicquel C, Bertherat B, Le Bouc Y & Bertagna X. Pathogenesis of adrenocortical incidentalomas and genetic syndromes associated with adrenocortical neoplasms. Endocrinology and Metabolism Clinics of North America 2000 29 1-13.
2. Luton JP, Cerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X et al. Clinical features of adrenocortical carcinoma, prognostic factors and the effect of mitotane therapy. New England Journal of Medicine 1990 322 1195-1201.
3. Bertherat J, Mosnier-Pudar H & Bertagna X. Adrenal incidentalomas. Current Opinion in Oncology 2002 14 58-63.
4. Gross MD, Shapiro B, Francis IR, Glazer GM, Bree RL, Arcomano MA et al, Scintigraphic evaluation of clinically silent adrenal masses. Journal of Nuclear Medicine 1994 35 1145-1152.
5. Kloos RT, Gross MD, Francis IR, Korobkin M & Shapiro B. Incidentally discovered adrenal masses. Endocrine Reviews 1995 16 460-484.
6. Gould MK, Maclean CC, Kuschner WG, Rydzak CE & Owen DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. Journal of the American Medical Association 2001 285 914-924.
7. Boland GW, Goldberg MA, Lee MJ, Mayo-Smith WW, Dixon J, McNicholas MM et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-(F-18)-fluoro-2-deoxy-D-glucose. Radiology 1995 194 131-134.
8. Erasmus JJ, Patz EF, McAdams HP, Murray JG, Herndon J, Coleman RE et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. American Journal of Roentgenology 1997 168 1357-1360.
9. 18F-FDGPET in characterizing adrenal lesions detected on CT or MRI. Journal of Nuclear Medicine 2001 42 1795-1799.
10. Maurea S, Klain M, Mainolfi C, Ziviello M & Salvatore M. The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses. Journal of Nuclear Medicine 2001 42 884-892.
11. Becherer A, Vierhapper H, Potzi C, Karanikas G, Kurtaran A, Schmaljohann J et al. FDG-PET in adrenocortical carcinoma. Cancer Biotherapy and Radiopharmaceuticals 2001 16 289-295.
12. Ludwig V, Rice MH, Martin WH, Kelley MC & Delbeke D. 2-deoxy-2-[18F]-D-glucose positron emission tomography uptake in a giant adrenal myelolipoma. Molecular Imaging and Biology 2002 4 355-358.
13. Shimizu A, Oriuchi N, Tsushima Y, Higuchi T, Aoki J & Endo K. High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome. Annals of Nuclear Medicine 2003 17 403-406.
14. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM & Mueller PR. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. American Journal of Roentgenology 1998 171 201-204.
15. Lin EC & Helgans R. Adrenal hyperplasia in Cushing's syndrome demonstrated by FDG positron emission tomographic imaging. Clinical Nuclear Medicine 2002 27 516-517.